Recombinant Human APOA4 Protein(Sumo Tag)

Recombinant Human APOA4 Protein(Sumo Tag)
Artikelnummer
ELSPDEH100609-500
Verpackungseinheit
500μg
Hersteller
Elabscience Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Protein Tag: N-Sumo

Uniprot: P06727

Accession: P06727

Background: Apolipoprotein is genetically associated with the risk of Alzheimer's disease (AD). The APOA1, APOC3, and APOA4 genes are closely linked and located on human chromosome 11. There was a decreased trend for levels of APOA1, APOC3, and APOA4 in AD patients. CONCLUSION: Low levels of APOA1, APOC3, and APOA4 are associated with risk of AD. APOA1, APOC3, and APOA4 should be developed as combined drμgs for the therapy of AD. SNP(single nucleotide polymorphisms)in APOA1and APOA4 genes influences atherogenic characteristics of LDL particles in response to diet.

Bio Acitivity: Not validated for activity

Sequence: Ser23-Ser396

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin: < 10 EU/mg of the protein as determined by the LAL method.

Calculated MW: 54 kDa

Observed MW: 60 kDa
Mehr Informationen
Artikelnummer ELSPDEH100609-500
Hersteller Elabscience Biotechnology
Hersteller Artikelnummer PDEH100609-500
Verpackungseinheit 500μg
Mengeneinheit STK
Reaktivität Human
Wirt Escherichia Coli
Produktinformation (PDF)
×
MSDS (PDF)
×